Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    I. Ralph Edwards, Marie Lindquist, editors.
    Contents:
    1. How to learn Pharmacovigilance, now and in the Future
    2. Lost in Regulation
    3. What is the Future of Pharmacovigilance and how can we Make it as Good as Possible?
    4. Some Other Ideas About the Future of Pharmacovigilance
    5. Best Safety Practices now and in the Future
    6. Is There a Benefit from the Medical Literature Monitoring Service of the EMA?
    7. The Unified Drug Safety-Clinical Database
    8. Behind the Scenes
    'Silent Factors' Influencing Pharmacovigilance Practice and Decisions
    9. Shaking up Culture and Communication in PV [V6]
    10. Broadening the Scope of Pharmacovigilance
    11. Effective Treatment Matters: Revitalizing Pharmacoviglance
    12. There are More Weber-Effects
    13. Herbal and Traditional Medicines, Now and Future
    14. The Concept of 'Health'
    15. Impact of Referral Procedures on the Interaction of RMP and PSUR
    16. Other Sources of Information for Monitoring Drug Safety: Now and in the Future
    17. Ecopharmacovigilance.
    Digital Access Springer 2017
  • Article
    Tanaka T, Nakagawa H, Kato A, Yoshimura M, Fujita H, Kimura K.
    Gan. 1977 Feb;68(1):45-52.
    In a syngeneic mouse-tumor system, anti-thymocyte serum, anti-macrophage serum, and latex particles were used for a comparative study of the immunotherapeutic efficacy of intradermal inoculation of tumor cell-BCG and tumor cell-Corynebacterium liquefaciens (=Propionibacterium acnes C7) vaccines. Anti-thymocyte serum treatment nullified suppression of tumor mediated by BCG (living and nonliving) and living C. liquefaciens. However, the effect of nonliving C. liquefaciens was not affected so much by treatment with anti-thymocyte serum. Treatment with anti-macrophage serum or latex particles also imparied the therapeutic efficacy of living BCG, but had no influence on the efficacy of living and nonliving C. liquefaciens.
    Digital Access Access Options